ClinicalTrials.gov
ClinicalTrials.gov Menu

Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) (100207MS-H)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01432704
Recruitment Status : Completed
First Posted : September 13, 2011
Last Update Posted : September 13, 2011
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Merja Soilu-Hänninen, University of Turku

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2011
  Actual Study Completion Date : August 2011